Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy CVS Health Corporation stock
Learn how to easily invest in CVS Health Corporation stock.
CVS Health Corporation is a healthcare plans business based in the US. CVS Health Corporation shares (CVS) are listed on the NYSE and all prices are listed in US Dollars. CVS Health Corporation employs 213,000 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in CVS Health Corporation
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CVS – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- CVS shares summary
- Compare share dealing platforms
- Is CVS stock a buy or sell?
- Stock performance over time
- Is CVS suitable for ethical investing?
- Are CVS shares over-valued?
- CVS Health Corporation's financials
- How volatile are CVS shares?
- Does CVS Health Corporation pay a dividend?
- Have CVS shares ever split?
- Other common questions
CVS Health Corporation stock price (NYSE: CVS)Use our graph to track the performance of CVS stocks over time.
CVS Health Corporation shares at a glance
|Latest market close||$101.56|
|52-week range||$66.78 - $107.26|
|50-day moving average||$97.77|
|200-day moving average||$87.05|
|Wall St. target price||$113.04|
|Dividend yield||$2 (2.07%)|
|Earnings per share (TTM)||$5.72|
Buy CVS Health Corporation shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy CVS Health Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
CVS Health Corporation price performance over time
|1 week (2022-01-13)||-3.59%|
|1 month (2021-12-18)||N/A|
|3 months (2021-10-18)||N/A|
|6 months (2021-07-22)||22.91%|
|1 year (2021-01-22)||37.02%|
|2 years (2020-01-22)||37.22%|
|3 years (2019-01-22)||56.44%|
|5 years (2017-01-20)||24.52%|
Is CVS Health Corporation stock undervalued or overvalued?
Valuing CVS Health Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CVS Health Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
CVS Health Corporation's P/E ratio
CVS Health Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 17x. In other words, CVS Health Corporation shares trade at around 17x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
CVS Health Corporation's PEG ratio
CVS Health Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.0889. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into CVS Health Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
CVS Health Corporation's EBITDA
CVS Health Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $17.8 billion.
The EBITDA is a measure of a CVS Health Corporation's overall financial performance and is widely used to measure a its profitability.
CVS Health Corporation financials
|Revenue TTM||$284 billion|
|Operating margin TTM||4.68%|
|Gross profit TTM||$48.2 billion|
|Return on assets TTM||3.55%|
|Return on equity TTM||1060.13%|
|Market capitalisation||$140.2 billion|
TTM: trailing 12 months
CVS Health Corporation's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like CVS Health Corporation.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
CVS Health Corporation's total ESG risk score
Total ESG risk: 18.73
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and CVS Health Corporation's overall score of 18.73 (as at 12/31/2018) is excellent – landing it in it in the 19th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like CVS Health Corporation is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
CVS Health Corporation's environmental score
Environmental score: 1.92/100
CVS Health Corporation's social score
Social score: 9.06/100
CVS Health Corporation's governance score
Governance score: 2.75/100
CVS Health Corporation's controversy score
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. CVS Health Corporation scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that CVS Health Corporation hasn't always managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
|Total ESG score||18.73|
|Total ESG percentile||18.84|
|Level of controversy||3|
CVS Health Corporation share dividends
Dividend payout ratio: 26.52% of net profits
Recently CVS Health Corporation has paid out, on average, around 26.52% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.07% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), CVS Health Corporation shareholders could enjoy a 2.07% return on their shares, in the form of dividend payments. In CVS Health Corporation's case, that would currently equate to about $2 per share.
While CVS Health Corporation's payout ratio might seem fairly standard, it's worth remembering that CVS Health Corporation may be investing much of the rest of its net profits in future growth.
CVS Health Corporation's most recent dividend payout was on 31 January 2022. The latest dividend was paid out to all shareholders who bought their shares by 19 January 2022 (the "ex-dividend date").
Have CVS Health Corporation's shares ever split?
CVS Health Corporation's shares were split on a 2:1 basis on 6 June 2005. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your CVS Health Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for CVS Health Corporation shares which in turn could have impacted CVS Health Corporation's share price.
CVS Health Corporation share price volatility
Over the last 12 months, CVS Health Corporation's shares have ranged in value from as little as $66.7817 up to $107.26. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while CVS Health Corporation's is 0.8414. This would suggest that CVS Health Corporation's shares are less volatile than average (for this exchange).
CVS Health Corporation overview
CVS Health Corporation provides health services in the United States. The company's Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail order, mail order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. Its Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. As of December 31, 2020, it operated approximately 9,900 retail locations and 1,100 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies.
CVS Health Corporation in the news
CVS Health (CVS) Stock Moves -0.81%: What You Should Know
Cfm Wealth Partners Llc Buys Axcelis Technologies Inc, Tenable Holdings Inc, KKR Inc, Sells ...
CVS Health to Invest $6.5 Million in Affordable Housing in Denver
Frequently asked questionsWhat percentage of CVS Health Corporation is owned by insiders or institutions?
Currently 0.171% of CVS Health Corporation shares are held by insiders and 78.742% by institutions. How many people work for CVS Health Corporation?
Latest data suggests 213,000 work at CVS Health Corporation. When does the fiscal year end for CVS Health Corporation?
CVS Health Corporation's fiscal year ends in December. Where is CVS Health Corporation based?
CVS Health Corporation's address is: One CVS Drive, Woonsocket, RI, United States, 02895 What is CVS Health Corporation's ISIN number?
CVS Health Corporation's international securities identification number is: US1266501006 What is CVS Health Corporation's CUSIP number?
CVS Health Corporation's Committee on Uniform Securities Identification Procedures number is: 126650100
More guides on Finder
Today’s top U.S. stocks: Mechel Pao ADRs (MTL ↑8.1%), Sibanye-Stillwater Limited (SBSW ↑7.4%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
How to order free at-home COVID tests today — but note, there’s a wait
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
Today’s top U.S. stocks: Las Vegas Sands (LVS ↑15.3%), Wynn Resorts Limited (WYNN ↑9.1%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut savings review
Donut earns up to 10% APY, but you must have an iOS device.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Tesla roars into 2022 after December drop
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
Ask an Expert